|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.98 SEK | +1.63% |
|
-2.35% | +26.72% |
| 04-26 | Dextech Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
| 04-15 | DexTech Medical Announces New Positive Results from the Myeloma Study | CI |
Dextech Medical AB reported earnings results for the first quarter ended September 30, 2023. For the first quarter, the company reported sales was SEK 1.65 million compared to SEK 0.943 million a year ago. Net loss was SEK 0.917 million compared to SEK 0.815 million a year ago.
Basic loss per share from continuing operations was SEK 0.05 compared to SEK 0.04 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +26.72% | 8.44M | |
| +2.97% | 108B | |
| +10.21% | 105B | |
| +1.57% | 23.46B | |
| -12.77% | 21.72B | |
| -7.05% | 18.64B | |
| -37.64% | 17.45B | |
| -6.50% | 17.19B | |
| +6.00% | 13.99B | |
| +37.20% | 12.53B |
DEXTECH MEDICAL AB 
